Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

Clinical trial NCT05708859 · RECRUITING

Trial details

NCT number: NCT05708859
Sponsor: Matthew J. Budoff
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type II Diabetes Atherosclerosis

Start date: 2024-01-02
Primary completion: 2025-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.